# Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave Lithotripsy

> **NCT01560091** · PHASE3 · WITHDRAWN · sponsor: **Albert Einstein Healthcare Network**

## Conditions studied

- Kidney Stones

## Interventions

- **DRUG:** silodosin
- **PROCEDURE:** Extra-corporeal shock wave lithotripsy
- **DRUG:** Tamsulosin

## Key facts

- **NCT ID:** NCT01560091
- **Lead sponsor:** Albert Einstein Healthcare Network
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-03
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** accrual of subjects did not occur as anticipated
- **Last updated:** 2017-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01560091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01560091, "Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave Lithotripsy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01560091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*